Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Sep 27 2024

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-27-2024-8

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 27, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases